Gilteritinib,midostaurin,quizartinib
Astellas Pharmaceuticals,daiichi sankyo,novartis
['leusm']
#eha22 #leusm zeidan: gilt will hold position as approved monotherapy for rr disease for now, but quiz will almost certainly find approval in fl to challenge mido soon 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)